Journal info
|
||
Select Journal
Journals
Bratislava Medical Journal Endocrine Regulations General Physiology and Biophysics Neoplasma 2024 Ahead of print 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 Acta Virologica Studia Psychologica Cardiology Letters Psychológia a patopsych. dieťaťa Kovove Materialy-Metallic Materials Slovenská hudbaWebshop Cart
Your Cart is currently empty.
Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.
Neoplasma Vol.65, No.1, p.49-54, 2018 |
||
Title: MicroRNA-421 inhibits caspase-10 expression and promotes breast cancer progression | ||
Author: T.B. HU, H.S. CHEN, M.Q. CAO, F.D. GUO, X.Y. CHENG, Z.B. HAN, M.Q. LI | ||
Abstract: Breast cancer is one of the most prevalent and fatal diseases around the world. The mechanism of tumorigenesis in breast cancer remains to be clarified. miR-421 plays an oncogenic role in many cancers. Although, the clinical significance of miR-421 in patients with breast cancer is still to be investigated. Caspase-10 is one of the initiator of apoptosis. But the relationship between miR-421 and caspase-10 has not been investigated. In the present study, we found that miR-421 was expressed much higher in breast cancer tissues compared to those in adjacent non-tumor tissues. Furthermore, miR-421 promotes cell proliferation and colony formation in vitro. miR-421 inhibits cell apoptosis probably through restraining caspase-10 expression. Thus, miR-421 might be a potential diagnostic maker and therapeutic target for breast cancer. |
||
Keywords: miRNA-421, caspase-10, apoptosis, breast cancer | ||
Published online: 11-Jan-2018 | ||
Year: 2018, Volume: 65, Issue: 1 | Page From: 49, Page To: 54 | |
doi:10.4149/neo_2018_170306N159 |
||
|
download file |
|